H3B-6545+palbociclib in patients (pts) with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (-) breast cancer (BC)

被引:0
作者
Johnston, Stephen R. D.
Pluard, Timothy J.
Wang, Judy S.
Hamilton, Erika P.
Song, Tingting
Rong, Yuanxin
Yamaguchi, Kohei
Juric, Dejan
机构
[1] Royal Marsden NHS Fdn Trust, London, England
[2] St Lukes Canc Inst, Kansas City, MO USA
[3] Florida Canc Specialists, Sarah Cannon Res Inst, Sarasota, FL USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Eisai Inc, Nutley, NJ USA
[6] Eisai & Co Ltd, Tokyo, Japan
[7] Harvard Med Sch, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1051
引用
收藏
页数:1
相关论文
empty
未找到相关数据